Thats my takeaway also, rapidly progressing towards a phase 2a and phase 2b clinical trial with a second indication yet to be announced.
This places IHL in the big leagues alongside Compass Pathways and Mind Med, both with US$ billion market caps.
Aussie investors don’t have long before the US investors will take control of the register and price IMO. I predict a lot of regret from some punters who had all the information, all the time in the world but sold before the real value was created.
- Forums
- ASX - By Stock
- IHL
- Ann: HREC and FDA pre-IND request for Psilocybin Therapy
Ann: HREC and FDA pre-IND request for Psilocybin Therapy, page-15
-
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online